Agios Pharmaceuticals AGIO

-
-
-
已收盤:-

淨值比明細

年季
收盤價
權益總計(百萬)
稅後權益報酬率(%)
稅後純益(百萬)
稅後資產報酬率(%)
資產總計(百萬)
2024Q1 29.24 744 -10.49 -82 -9.13 850
2023Q4 22.27 811 -11.30 -96 -9.87 937
2023Q3 24.75 887 -9.87 -91 -8.73 1,007
2023Q2 28.32 964 -8.38 -84 -7.49 1,085
2023Q1 22.97 1,037 -7.58 -81 -6.78 1,151
2022Q4 28.08 1,101 3.40 37 3.02 1,239
2022Q3 28.28 1,050 -7.52 -82 -6.72 1,180
2022Q2 22.17 1,124 -7.88 -92 -7.09 1,252
2022Q1 29.11 1,207 -7.58 -95 -6.83 1,336
2021Q4 32.87 1,292 -7.04 -95 -6.35 1,438
2021Q3 46.15 1,395 -5.70 -89 -5.20 1,541
2021Q2 55.11 1,722 -4.29 -86 -3.95 1,875
2021Q1 51.64 2,297 139.04 1,874 112.19 2,488
2020Q4 43.33 400 -22.20 -98 -11.09 853
2020Q3 35.00 480 -19.05 -99 -10.50 908
2020Q2 53.48 558 -15.29 -90 -10.19 976
2020Q1 35.48 625 -6.36 -40 -4.76 800
2019Q4 47.75 641 -18.80 -102 -12.88 891
2019Q3 32.40 448 -21.65 -106 -14.32 699
2019Q2 49.88 533 -19.06 -110 -13.68 784